Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

[1]  Yixiang Wang,et al.  The prognostic value of glycerol‐3‐phosphate dehydrogenase 1‐like expression in head and neck squamous cell carcinoma , 2014, Histopathology.

[2]  Marcin Skrzypski,et al.  Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes. , 2013, Clinical lung cancer.

[3]  S. Gabriel,et al.  Pan-cancer patterns of somatic copy-number alteration , 2013, Nature Genetics.

[4]  Yu Liu,et al.  Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysis , 2013, Cancer Chemotherapy and Pharmacology.

[5]  Edward S. Kim,et al.  Validation of a Proliferation-Based Expression Signature as Prognostic Marker in Early Stage Lung Adenocarcinoma , 2013, Clinical Cancer Research.

[6]  J S Liu,et al.  Gene-expression data integration to squamous cell lung cancer subtypes reveals drug sensitivity , 2013, British Journal of Cancer.

[7]  K. Rabe,et al.  Management of non-small-cell lung cancer: recent developments , 2013, The Lancet.

[8]  M. Tenhagen,et al.  p120-catenin in cancer – mechanisms, models and opportunities for intervention , 2013, Journal of Cell Science.

[9]  D. Elliott,et al.  Expression of Tra2β in Cancer Cells as a Potential Contributory Factor to Neoplasia and Metastasis , 2013, International journal of cell biology.

[10]  M. Segal,et al.  Analytical Validation of a Practical Molecular Assay Prognostic of Survival in Nonsquamous Non–Small Cell Lung Cancer , 2013, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[11]  L. Paz-Ares,et al.  DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification. , 2013, Carcinogenesis.

[12]  J. Mesirov,et al.  β-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis , 2013, Cell.

[13]  M. Martinka,et al.  Sox4 Mediated Dicer Expression is Critical for Suppression of Melanoma Cell Invasion , 2012, Oncogene.

[14]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[15]  D. Drubin,et al.  Myosin 1E coordinates actin assembly and cargo trafficking during clathrin-mediated endocytosis , 2012, Molecular biology of the cell.

[16]  J. Hofsteenge,et al.  Structure of human POFUT2: insights into thrombospondin type 1 repeat fold and O‐fucosylation , 2012, The EMBO journal.

[17]  Matthew D. Wilkerson,et al.  Differential Pathogenesis of Lung Adenocarcinoma Subtypes Involving Sequence Mutations, Copy Number, Chromosomal Instability, and Methylation , 2012, PloS one.

[18]  Jian-yong Li,et al.  Downregulated Dicer expression predicts poor prognosis in chronic lymphocytic leukemia , 2012, Cancer science.

[19]  Michael Schroeder,et al.  Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes , 2012, PLoS Comput. Biol..

[20]  Elisabeth Brambilla,et al.  Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities , 2012, Clinical Cancer Research.

[21]  Aedín C. Culhane,et al.  GeneSigDB: a manually curated database and resource for analysis of gene expression signatures , 2011, Nucleic Acids Res..

[22]  Maria Ortiz-Estevez,et al.  Getting DNA copy numbers without control samples , 2012, Algorithms for Molecular Biology.

[23]  L. Holmberg,et al.  Gene Copy Number Aberrations Are Associated with Survival in Histologic Subgroups of Non-small Cell Lung Cancer , 2011, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[24]  S. Thorgeirsson,et al.  Genes Associated with Recurrence of Hepatocellular Carcinoma: Integrated Analysis by Gene Expression and Methylation Profiling , 2011, Journal of Korean medical science.

[25]  Xihong Lin,et al.  Impact on Disease Development, Genomic Location and Biological Function of Copy Number Alterations in Non-Small Cell Lung Cancer , 2011, PloS one.

[26]  D. Horst,et al.  Overexpression of Dicer predicts poor survival in colorectal cancer. , 2011, European journal of cancer.

[27]  David Tuck,et al.  GPHMM: an integrated hidden Markov model for identification of copy number alteration and loss of heterozygosity in complex tumor samples using whole genome SNP arrays , 2011, Nucleic acids research.

[28]  I. Petersen,et al.  Frequent and Focal FGFR1 Amplification Associates with Therapeutically Tractable FGFR1 Dependency in Squamous Cell Lung Cancer , 2010, Science Translational Medicine.

[29]  J. Yokota,et al.  MYC Amplification as a Prognostic Marker of Early-Stage Lung Adenocarcinoma Identified by Whole Genome Copy Number Analysis , 2010, Clinical Cancer Research.

[30]  Igor Jurisica,et al.  Prognostic and predictive gene signature for adjuvant chemotherapy in resected non-small-cell lung cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  K. Shroyer,et al.  O-fucosylation of thrombospondin type 1 repeats restricts epithelial to mesenchymal transition (EMT) and maintains epiblast pluripotency during mouse gastrulation. , 2010, Developmental biology.

[32]  Christopher R. Cabanski,et al.  Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types , 2010, Clinical Cancer Research.

[33]  Angel Rubio,et al.  ACNE: a summarization method to estimate allele-specific copy numbers for Affymetrix SNP arrays , 2010, Bioinform..

[34]  L. Stewart,et al.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data , 2010, The Lancet.

[35]  G. Gerlitz.  HMGNs, DNA repair and cancer. , 2010, Biochimica et biophysica acta.

[36]  A. Regev,et al.  SOX2 Is an Amplified Lineage Survival Oncogene in Lung and Esophageal Squamous Cell Carcinomas , 2009, Nature Genetics.

[37]  Marshall W. Anderson,et al.  Haplotype and cell proliferation analyses of candidate lung cancer susceptibility genes on chromosome 15q24-25.1. , 2009, Cancer research.

[38]  E. Stickeler,et al.  Significance of nuclear hTra2‐beta1 expression in cervical cancer , 2009, Acta obstetricia et gynecologica Scandinavica.

[39]  Kenta Nakai,et al.  PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.

[40]  Marcin Skrzypski,et al.  Three-Gene Expression Signature Predicts Survival in Early-Stage Squamous Cell Carcinoma of the Lung , 2008, Clinical Cancer Research.

[41]  Richard J Stephens,et al.  Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  G. Mills,et al.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 , 2008, Nature Genetics.

[43]  J. Crowley,et al.  The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours , 2007, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[44]  N. Hayward,et al.  Expression profiling defines a recurrence signature in lung squamous cell carcinoma. , 2006, Carcinogenesis.

[45]  J. Stuart,et al.  DNA repair and cancer. , 2007 .

[46]  Rajiv Dhir,et al.  Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. , 2006, The American journal of pathology.

[47]  Yi Zhang,et al.  Gene expression signatures for predicting prognosis of squamous cell and adenocarcinomas of the lung. , 2006, Cancer research.

[48]  S. Hirohashi,et al.  Genetic Classification of Lung Adenocarcinoma Based on Array-Based Comparative Genomic Hybridization Analysis: Its Association with Clinicopathologic Features , 2005, Clinical Cancer Research.

[49]  M. Wigler,et al.  Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.

[50]  Sunil J Rao,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2003 .